As the COVID-19 pandemic grows, it is essential for healthcare professionals and European citizens to have access to more disinfectants. To improve this access, there is a need to increase the manufacture and supply of these products. That’s why ECHA is supporting EU/EEA authorities to apply derogations from the normal authorisation requirement for biocidal products.
ECHA annouces that companies looking to quickly access the market with their disinfectants that contain an already approved active substance, can apply for permission to the relevant national authority by relying on Article 55(1) of the Biocidal Products Regulation (BPR). This provision allows national authorities to give time-limited derogations from the standard product authorisation requirements in situations where there is a threat to public health.
Several EU/EEA countries have already granted such permissions to companies that have the capacity to manufacture disinfectants. For applications that target several countries, a centralised submission to ECHA is being developed. More information about that will follow in the coming days.
ECHA is also recommending certain compositional requirements for the two approved active substances, propan-1-ol and propan-2-ol, for their use in disinfectants. These recommendations will enable national authorities to swiftly check the quality of the incoming applications before deciding on a derogation.
Furthermore, to ease the work of authorities and for companies looking for information, ECHA is making three lists available with information on:
• Biocidal active substances approved or being reviewed for their use in disinfectant products
• Disinfectant products that are authorised under the Biocidal Products Regulation (BPR), and
• Disinfectant products authorised …
